Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2016

View Archived Issues

Novel neuroprotective agent shows potential for autism spectrum disorders

Phase II trial explores use of glembatumumab vedotin in recurrent or refractory osteosarcoma

BMS initiates phase II trial of BMS-986142 in patients with rheumatoid arthritis

Bellicum Pharmaceuticals' BPX-501 granted FDA orphan drug designation

Sanofi Pasteur announces first vaccinations with Dengvaxia in Philippines

FDA grants breakthrough therapy designation for oliceridine

PeptiDream and JCR Pharmaceuticals sign joint research agreement

Endo and BioDelivery announce launch of Belbuca buccal film for chronic pain management

OBI Pharma reports topline results for OBI-822/821 in patients with metastatic breast cancer

Formula and Rockland to develop a novel immunotherapy cancer pipeline

Boehringer Ingelheim Pharma discloses neutrophil elastase inhibitors

Nuevolution announces Brd4 inhibitors

Janssen Pharmaceutica patents mGlu2 receptor negative allosteric modulators

Rockwell files IND to study Triferic for iron-refractory iron-deficiency anemia

Capricor initiates phase I/II trial of CAP-1002 in DMD-related cardiomyopathy

Russian Ministry of Health accepts Pharmstandard's filing for tivozanib in RCC

Unilife and Amgen establish strategic collaboration for injectable drug delivery systems

FDA approves revised product label for Epicel

FDA lifts clinical hold on Aeolus's AEOL-10150 in acute radiation syndrome

Phase II results for armodafinil for fatigue in patients with gliomas undergoing radiotherapy

Breast Cancer Research Foundation launches collaborative breast cancer funding model

Seattle Genetics starts phase I/II trial of vadastuximab talirine in MDS

Axxam and NEOMED Institute to develop FFA4 receptor agonists for metabolic disorders

Myriad Genetics test chosen to evaluate response in phase I/II trial of niraparib and pembrolizumab

EUROIMMUN Zika virus tests launched in U.S. for research use

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026